Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

292

HTML

2112

Figures (1-2)

133

Tables (1-3)

156

Sum=2693

Jun 28, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jun 28, 2005; 11(24): 3724-3728
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3724

Figure 1 Expressed VEGF (A) and COX-2 (B) in gallbladder carcinoma (S-P ×400).

Figure 2 Immunohistochemical staining of CD₃₄ in gallbladder carcinoma tissue (S-P ×200).

Citation: Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3724-3728
URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3724.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i24.3724